End stopping in V1 is sensitive to contrast.

Nature Neuroscience
Arash Yazdanbakhsh, M S Livingstone

Abstract

Common situations that result in different perceptions of grouping and border ownership, such as shadows and occlusion, have distinct sign-of-contrast relationships at their edge-crossing junctions. Here we report a property of end stopping in V1 that distinguishes among different sign-of-contrast situations, thereby obviating the need for explicit junction detectors. We show that the inhibitory effect of the end zones in end-stopped cells is highly selective for the relative sign of contrast between the central activating stimulus and stimuli presented at the end zones. Conversely, the facilitatory effect of end zones in length-summing cells is not selective for the relative sign of contrast between the central activating stimulus and stimuli presented at the end zones. This finding indicates that end stopping belongs in the category of cortical computations that are selective for sign of contrast, such as direction selectivity and disparity selectivity, but length summation does not.

References

Oct 1, 1978·The Journal of Physiology·J A MovshonD J Tolhurst
Aug 1, 1992·Visual Neuroscience·D J Heeger
Jul 1, 1992·Journal of Neurophysiology·G C DeAngelisR D Freeman
Sep 17, 1992·Nature·Z J He, K Nakayama
Jan 1, 1989·Vision Research·A DobbinsM S Cynader
Jul 1, 1987·Journal of Neurophysiology·R C EmersonS A Klein
Jan 1, 1987·Experimental Brain Research·K TanakaR D Freeman
Jul 1, 1986·Journal of Neurophysiology·I Ohzawa, R D Freeman
May 1, 1984·Perception & Psychophysics·J BeckR Ivry
Jan 1, 1994·Journal of Neurophysiology·G C DeAngelisI Ohzawa
Nov 1, 1993·Vision Research·T Watanabe, P Cavanagh
Jan 1, 1993·Spatial Vision·T Watanabe, P Cavanagh
Dec 1, 1996·Cognitive Psychology·J Driver, G C Baylis
Apr 16, 1998·Neuron·M S Livingstone
Nov 3, 1998·Vision Research·R A Rensink, J T Enns
Jun 30, 2001·Neuron·M S LivingstoneR T Born
Nov 9, 2002·Journal of Neurophysiology·James R CavanaughJ Anthony Movshon
Feb 11, 2003·Neuron·Christopher C PackMargaret S Livingstone
May 13, 2003·Journal of Neurophysiology·Margaret S Livingstone, Bevil R Conway
May 1, 1954·Psychological Review·F ATTNEAVE
Nov 25, 2005·Cerebral Cortex·Piers D L Howe, Margaret S Livingstone

❮ Previous
Next ❯

Citations

Feb 13, 2009·Cerebral Cortex·Katharina Anton-ErxlebenStefan Treue
Jan 16, 2013·Current Opinion in Psychiatry·Dragan M SvrakicClaude R Cloninger
May 2, 2014·PloS One·Charles AissaniJean Lorenceau
Apr 5, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christopher A HenryMichael J Hawken
Nov 29, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christian QuaiaBruce G Cumming
Jul 26, 2011·Neural Networks : the Official Journal of the International Neural Network Society·Simone GoriEnnio Mingolla
Jun 23, 2009·Trends in Neurosciences·Karin Nordström, David C O'Carroll
Sep 14, 2007·Current Opinion in Neurobiology·Bevil R Conway, Margaret S Livingstone
May 18, 2012·The European Journal of Neuroscience·Leo L LuiMarcello G P Rosa
Jul 26, 2011·Brain Research·Charles AissaniJean Lorenceau
Oct 16, 2013·Vision Research·B M SheligaB G Cumming
Jun 13, 2008·Perception·Simone Gori, Arash Yazdanbakhsh
Jan 16, 2008·Physiological Reviews·Guy A Orban
Sep 26, 2014·Journal of Neurophysiology·Yu-Cheng Pei, Sliman J Bensmaia
Sep 22, 2017·Journal of Neurophysiology·Jason M SamondsSandra J Kuhlman
Jun 3, 2021·Scientific Reports·Chia-Huei TsengChien-Chung Chen
Nov 14, 2021·Nature Communications·Roy HarpazFlorian Engert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.